EMEA-001659-PIP01-15-M06
Key facts
Invented name |
Crysvita
|
Active substance |
Burosumab
|
Therapeutic area |
Other
|
Decision number |
P/0411/2022
|
PIP number |
EMEA-001659-PIP01-15-M06
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of X-linked hypophosphataemia
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Kyowa Kirin Holdings B.V.
Tel. +44 (0)1896 664000 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|